Xilio Therapeutics Liabilities 2024

Liabilities Details

Assessing Xilio Therapeutics's Liabilities

Xilio Therapeutics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Xilio Therapeutics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Xilio Therapeutics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Xilio Therapeutics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Xilio Therapeutics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Xilio Therapeutics stock

What is the level of liabilities of Xilio Therapeutics this year?

Xilio Therapeutics has a debt balance of 24.1 M USD this year.

What were the liabilities of Xilio Therapeutics compared to the previous year?

The liabilities of Xilio Therapeutics have increased by -28.06% dropped compared to the previous year.

What are the consequences of high debt for investors of Xilio Therapeutics?

High liabilities can pose a risk for investors of Xilio Therapeutics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Xilio Therapeutics?

Low liabilities mean that Xilio Therapeutics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Xilio Therapeutics affect the company?

An increase in liabilities of Xilio Therapeutics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Xilio Therapeutics affect the company?

A decrease in the liabilities of Xilio Therapeutics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Xilio Therapeutics?

Some factors that can influence the liabilities of Xilio Therapeutics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Xilio Therapeutics so important for investors?

The liabilities of Xilio Therapeutics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Xilio Therapeutics take to modify the liabilities?

To change its liabilities, Xilio Therapeutics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Xilio Therapeutics pay?

Over the past 12 months, Xilio Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Xilio Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Xilio Therapeutics?

The current dividend yield of Xilio Therapeutics is .

When does Xilio Therapeutics pay dividends?

Xilio Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Xilio Therapeutics?

Xilio Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Xilio Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Xilio Therapeutics located?

Xilio Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Xilio Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Xilio Therapeutics from 9/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.

When did Xilio Therapeutics pay the last dividend?

The last dividend was paid out on 9/9/2024.

What was the dividend of Xilio Therapeutics in the year 2023?

In the year 2023, Xilio Therapeutics distributed 0 USD as dividends.

In which currency does Xilio Therapeutics pay out the dividend?

The dividends of Xilio Therapeutics are distributed in USD.